In obesity-related hypertension, compensatory effects, adiponectin resistance, and reduced adiponectin clearance from impaired kidneys and liver all contribute to the “adiponectin paradox”. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.